CAMBRIDGE, Mass.--(BUSINESS WIRE)--NinePoint Medical, Inc., an emerging leader in the development of medical devices for in vivo imaging, today announced that positive data from the company’s ongoing clinical trial to evaluate high-resolution optical imaging of Barrett’s esophagus using its proprietary NvisionVLE™ Imaging System will be presented at three key medical meetings in the U.S. and Europe. In the two studies conducted at the Mayo Clinic in Jacksonville, Fla. and Rochester, Minn., the NvisionVLE Imaging System’s high resolution and wide-field imaging enabled the detection of dysplasia that was missed with the standard biopsy protocol.
